Impact factor: /ICV:

Size: px
Start display at page:

Download "Impact factor: /ICV:"

Transcription

1 Impact factor: /ICV: Pharma Science Monitor 6(4), Oct-Dec 2015 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: A CLINICAL STUDY TO ASSESS THE EFFECT OF SAMVARDHANA GHRITA AND YOGA BASTI IN CEREBRAL PALSY Satyawati Rathia 1 *, V. K. Kori 2, Rajagopala S. 2, K. S. Patel 3, Suhas A. Chaudhary 4 1 Ph.D. Scholar, Dept. of Kaumarbhritya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar , India 2 Assistant Professor, Dept. of Kaumarbhritya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar , India 3 Professor, Dept. of Kaumarbhritya, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar , India. 4 Lecturer, Dept. of Kaumarbhritya, Shree Gulabkunverba Ayurveda Mahavidyalaya, Gujarat Ayurved University, Jamnagar , India. ABSTRACT Cerebral palsy refers to a group of neurological disorders that appear in infancy or early childhood and permanently affect body movement and muscle coordination.the prevalence of Cerebral Palsy among children is 2 per 1000 live births. In this study 8 patients were completed the treatment. Samvardhana Ghrita orally for 62 days and Udvartana (5days), Abhyanga (5days), Swedana (5days), and Yoga Basti (8 days) given for 86 days. Total 3 courses were done followed by 16 days interval between each course. Personal & Social milestone was improved. Yoga Basti shown improvement in growth (Height, Wei ght and Mid Arm Circumference), development milestone (sitting, standing, fine motor and personal and social).this study shows that improvement was observed in 12.5% patients. Ayurvedic treatment modality was effective in improving the milestones of Cerebral Palsy patients. KEYWORDS: Abhyanga, Cerebral Palsy, Samvardhana Ghrita, Swedana, Udvartana and Yoga Basti. INTRODUCTION Childhood period is considered as the foundation of the better future life and every incidence has influence on the further life. Disability is a major problem those effect the better life of children. While disability is discussed particularly in children, about a quarter of chronic childhood problems are neurological in origin. Cerebral palsy (CP) is caused by damage to or abnormalities inside the developing brain that disrupt the brain s ability to control movement and maintain posture and balance. The term cerebral refers to the brain; palsy refers to the loss or impairment of motor function [1]. In Cerebral palsy some conditions found in classics at different places like Pangulya, Mukatva, Jadatva, Ekanga Roga, Sarvanga Roga, Pakshaghata, Pakshavadha etc, under the group of Vatavyadhi [2]. Contributory factors are like inappropriate Ritu, Kshetra, Ambu

2 Impact factor: /ICV: and Bija [3], Dauhrida Avamanana [4], presence of Garbhopaghatkarbhava [5], incompatible Garbha Vriddhikarabhava [6] and improper following of Garbhini Paricharya [7]. Considering the signs and symptoms of CP, this disease seems very closer to the presentation of Vata Vyadhi. Basti is very helpful in pacifying Vata, further it is glorified that Basti Chikitsa as Ardha Chikitsa of Vata [8]. By these facts, Basti is most important among the Panchakarma in the treatment of CP. There are many types of Bsati. According to number Charak is described three types: Karma, Kala and yoga. This pattern of Basti includes the group of eight Basti, out of which five are Anuvasana and three are Niruha. The schedule is started with Anuvasana on the day one followed by three Niruha and three Anuvasana alternatively. Lastly, one Anuvasana is to be given [9]. Yoga Basti is indicated in Kaphanubandhi Vata Prakopa, Alpa bala and Vata Dosha vatiation [10]. No other Chikitsa has the capacity to pacify and regulate the force of Vata apart from Basti [11]. Same hypothesis was assumed for this clinical trial. Pakwashaya is the seat of Vata Dosha. Basti denotes Karma where the drugs administered through the rectal canal stay for certain period in the body. Then produce the coating of the Sneha in the body and draws out the waste substances from all over the body into the colon and eliminates them out of the body by producing movements in the colon resulting into pleasant (beneficial) effect. According to Charaka, Basti is the Karma in which, the medicine prepared according to classical references is administered through rectal rout and it reaches up to the Nabhi Pradesh, Kati, Parshwa, Kukshi (small intestine) churns the accumulated Dosha and Purisha, spreads the unctuousness (potency of drugs) all over the body and easily comes out along with the Purisha and Dosha (impurity) [12]. In Lehadhyaya chapter of Kashyapa Samhita, reference of such Lehana Yoga named Samvardhana Ghrita is promoting general growth, strength and intellect of children. This Ghrita is mentioned for smooth and rapid growth of child without interference of any disease for healthy child and improving or treating the conditions in Pangu (lame), Muka (dumb), Ashruti (deaf), Jada (idiot) [13]. This reveals the possible efficacy of Samvardhana Ghrita for improving the condition in CP or other similar conditions. MATERIALS AND METHOD Material Diagnosed patient of Cerebral palsy attending O.P.D. & I.P.D. of Kaumarbhritya Department, I.P.G.T. & R.A., Jamnagar were taken for the research work. Samvardhana Ghrita was collected from pharmacy of Gujarat ayurved university Jamnagar. Inclusion criteria:

3 Impact factor: /ICV: Age group - 1 year to 10 years of both sex. 2. Children with severe type of the disability (GMFCS Score upto level 5) were included in study. Exclusion criteria: 1. Children s age < 1 and > 10 years. 2. Children with major congenital disorders. 3. Children with other diseases ex. Juvenile diabetes, tuberculosis, acute infection etc. Method: Study Design: The randomized simple sampling method. LABORATORY INVESTIGATIONS: Blood : Hb, TC, DC, ESR, CRP (If needed) Urine : Routine and microscopic examinations. (If needed) Stool : Routine and microscopic examinations. (If needed) TRIAL OBJECTS: Drug : Samvardhana Ghrita Procedure : Udvartana, Abhyanga, Swedana and Yoga Basti STUDY DESIGN: Patients received Samvardhana Ghita for 62 day orally. Udvartana with Yava and Kulattha for 5 days, Abhyanga with Bala Taila + Nadi Sweda for 5 days and 8 days of Yoga Basti with 16 days of interval, Such 3 courses were repeated. Dose of Samvardhana Ghrita was determined by using reference of Sharngdhara Samhita [14]. (Table no.1) Dose of Basti Dravya is given as per the reference of Charaka Samhita [15] (Table no 2.) Doses for Aasthapana Basti. Anuvasana should be given ¼ of the quantity of Aasthapana Basti. Table 1 Age wise dose of Samvardhana Ghrita Age group Dose (Once / Day) 1 3 yrs. 2.5 gm. 4 7 yrs. 6 gm yrs. 9.5 gm. Sahapana Duration Follow up : Madhu : 62 days : 8 weeks

4 Impact factor: /ICV: Table no 2. Age wise dose of Aasthapana Basti Age in year Prasruta Tola Gms. 1yr 1/ yr yr 1 ½ yr yr 2 ½ yr yr 3 ½ yr yr 4 ½ yr Basti schedule:- Yoga basti was administer as per the schedule that is A N A N A N A A ASSESSMENT COMPONENTS: A= Anuvasana Basti, N= Niruha (Asthapana) Basti Assessment criteria include Centers for diseases Control and prevention(cdc) grading for motor milestones, suitable scoring pattern was prepared for Fine Motor, Language and Personal and Social milestones, Ashworth Scale to assess spasticity, Muscle Power grading, Manual Ability Classification System (MACS) to assess the function of upper limb, Gross Motor Functions Classification System (GMFCS) and Activities of Daily Living score (ADL) was taken as assessment criteria to observe the effect of therapy. Table no 3. ASSESSMENT OF TOTAL EFFECT OF THERAPY: Complete Remission Marked Improvement Moderate Improvement 100% improvement of clinical signs and symptoms. More than 75% to 99% improvements of clinical signs and symptoms. More than 50% to 75% improvement of clinical signs and symptoms. Mild Improvement More than 25% to 50% improvement of clinical signs and symptoms. Improvement More than 10% to 25% improvement of clinical signs and symptoms. Unchanged 0 to 10% improvements of clinical signs and symptoms. Worsened Less than 0% worsened of clinical signs and symptoms. Statistical analysis was done by using paired t and student unpaired t test. Discussion Samvardhana Ghrita Samvardhana Ghrita is described in Lehadhyaya chapter of Kashyapa Samhita. It is mentioned for smooth and rapid growth of child without interference of any disease for healthy

5 Impact factor: /ICV: child and improving or treating the impaired conditions in those who are Pangu (lame), Muka (dumb), Ashruti (deaf) and Jada (idiot) [16]. Table no 4. Ingredients of Samvardhana Ghrita: No Ingredients Latin name Part used Qty 1. Khadira Acasia catechu Willd Heart wood 1/7 2. Prishniparni Pseudarthria viscida Desv Whole plant 1/7 3. Syandana Ougenia dalbergiodes Benth Stem Bark 1/7 4. Bala Sida cordifolia Linn Whole plant 1/7 5. Atibala Abutilon indicum Linn Whole plant 1/7 6. Kebuka Costus speciosus Smith Rhizome 1/7 7. Saindhav Sodium Chloride - 1/7 8. Kshira Milk Ghrita Ghee - ½ 10. Jala Water - 4 Pharmacodynemic action of Ingredients of Samvardhana Ghrita are mentioned in Dravya Guna Vigyaniyam, Charak and Susruta Samhita [17-19]. Table no 5. Pharmacodynemic actions of Ingredients of Samvardhana Ghrita: No. Ingredients Rasa Guna Virya Vipaka Karma 1. Khadira Tikta, Laghu, Ruksha Sheeta Katu Pachana Kashaya 2. Prishniparni Madhura, Tikta Laghu, snigdha Ushna Madhura Balya, Vatahara, 3. Syandana Kashaya Laghu, Ruksha Sheeta Katu Rasayana 4. Bala Madhura Snigdha Sheeta Madhura Balya, Rasayana 5. Atibala Madhura Snigdha Sheeta Madhura Balya, Rasayana 6. Kebuka Tikta Laghu, Ruksha Sheeta Katu Deepana, Pachana, 7. Saindhav Lavana Snigdha, Ushna, Tikshna Anushna Sheeta and Madhura Deepana, Pachana Sheeta 8. Kshira Madhura Mridu, Snigdha Sheeta Madhura Medhya, 9. Ghrita Madhura Snigdha, Mridu, Guru 10. Jala Madhura Laghu, Sukshma,Vishada Observations: Balya Sheeta Madhura Medhya, Balya, Rasayana, Sheeta Madhura Medhya, Balya, Rasayana Total 8 Patients were completed the present study. In the clinical study maximum number of (45%) of the Patients belonged to age group of 4-7years and 82% were males. Majority of them belonged to Hindu religion (82%),middle socio -economic status(73%),education not started

6 Impact factor: /ICV: (91%).In antenatal history of mother Hyperemesis gravidarum(45%),infection(9%)and hypertension(18%),trauma, antepartum hemorrhage, were (5-5%).maximum patients were delivered in hospital(82%), LSCS(27%), Forceps delivery(9%), Preterm(27%),normal Birth Low birth weight(18%),very low birth weight(18%),delayed cried after birth(55%),convulsion, pathological jaundice and fever ( 36%), meconium aspiration(27%), birth asphyxia, cord around neck, septicemia (9%). Hospitalization was required (36%),Resuscitation(55%) according to feeding pattern during neonatal period Breast fed (45%) and Breast + bottle feeding (65%).Spastic CP (82%),Hypotonic (18%), severe type of CP (64%) and moderate type(27%) (25%) and mild type (9%). The signs and symptoms reported included, developmental delay, feeding problem, language impairment( %), vision problem, hearing problem and abnormal movements (9%) and mental retardation (36%),Spasticity, contractures were observed in 82%, 45%, patients respectively. Impaired co-ordination, impaired orientation, and poor head growth (Microcephal y) were found in 82%, 73%, and 45% patients, recurrent respiratory tract infection(18%), Bowel control Not Achieved (45%),Bladder control not achieved (55%), Feeding Difficulties and Excessive salivation (64%), Constipation (18%), Liquid(45%), semisolid(36%) and solid (18%), Proper immunization (100%), joint family(36%) and nuclear family(65%). Positive Family history(95% mothers age between years(9%) and fathers belong to 29-36years(9%), Parental history Abortion (11%),Primiparity(89%),H/o Consanguinity (18%) use of anti epileptic drug (AED)(9%) and Muscle relaxant (18%), physiotherapy was taken by 36% of patients. EFFECT OF THERAPY ON ASSESSMENT CRITERIA Anthropometric measurement Patients treated with Samvardhana Ghrita and Yoga Basti, improvement was found in length (0.12%), weight (1.75%), Chest circumference (0.27) and Mid thigh circumference(0.35) n=8 Percentage % Series 1 0 Length Weight Chest circumference Mid thigh circumference Figure 1. Effect of therapy on Anthropometric measurement

7 Impact factor: /ICV: Development milestone Patients treated with Samvardhana Ghrita and Yoga Basti, improvement was found in neck holding (8.33%), sitting (8.33%), standing (6.66%), Fine motor (7.7%) language (14.48%), personal and social milestones (17.29%) and gross motor classification system (GMFCS) (11.42%) % 18.00% 16.00% 14.00% 12.00% 10.00% 8.00% 6.00% 4.00% 2.00% 0.00% n=8 Series 1 Figure 2. Effect of therapy on Development milestone Probable mode of action: Most of the drugs in Samvardhana Ghrita are having Madhura, Tikta Rasa, Guru Guna, Shita Virya and Madhura Vipaka. As per available reference, drugs like Bala, Atibala, Mandukparni, Ghrita and Kshira is indicated for improving higher brain functions like Medha (Intellectual), Rasayana etc. Indication of Sanvardhana Ghrita in Vaka, Medha, Smruti, Buddhi enhancement, shows its efficacy to target motor, sensory and higher functions. Main causation of Vata is observed and with the use of this Ghrita probable correction takes places at vitiated Vata level and thereby improving in these parameters and clinical signs and symptoms of Cerebral Palsy. Medhya property of Samvardhana Ghrita has also improved Personal & Social milestone in this study.so indication of Samvardhana Ghrita in Vaka, Medha, Smruti, Buddhi enhancement, shows its efficacy to target motor, sensory and higher functions. Udvartana with rukshana effect removes vitiated kapha and ama dosha, clears the orifices of hair follicles and improves lymphatic and blood circulation which is helpful to absorption the drugs to the target site [20]. Abhyanga nourishes the Dhatu and increases their strength. It corrects and prevents disorders caused by affliction of Vata. It helps in the promotion and regulation of the proper functioning of Vata [21]. Swedana relieves stiffness, heaviness and coldness of the body [22].This study shown increased muscle bulk, power and diminished muscle tone through Abhyanga procedure and

8 Impact factor: /ICV: decreased stiffness of body by Swedana Karma. Improvement in muscle bulk, power, tone and developmental milestones with Yoga Basti included, Anuvasana Basti is more beneficial particularly in affliction of Vata [23]. It has Vata Shamana, Balya and Dhatu Poshana and Asthapana Basti (Madhutailika) has Dosha Nirharana properties which removes morbid dosha and to gain strength and complexion [24]. Basti dravya prepared by various drugs like madhu, taila influences the normal bacteria flora of the colon.so vitamin B12 synthesis is increases, which has an important role in the repair and regeneration of nerves [25]. Thus, Udvartana, Abhyanga, Swedana and Yoga Basti act on sharira and manas brumhana. CONCLUSION Samvardhana Ghrita and Yoga Basti is effective in relieving the signs and symptoms and reducing the disability in children with CP.This study, shown result in improving the disease condition. More outcomes is observed in improving the milestones Growth and Motor components, language, personal and social leads to more effectual protocol of combined treatment (Internal medication as well as Panchakarma procedures). ACKNOWLEDGEMENT Author is thankful to his guide and co-guides for their encouragement towards research work. REFERENCES 1. July 2, Agnivesha, Charaka, Drihabala, Charaka Samhita,Sutrasthana, Maharogaadhyaya, 20/11, edited by Dr. Brahmanand Tripathi, Chaukhambha Surbharti Prakashana, Varanasi, 2012; p Devodas Dhanvantari,Sushruta, Susruta Samhita, Sharira Sthana Shukrashonitashuddhisharira adhyaya,2/33,edited by Ambika Dutta Shastri, Chaukhambha Sanskrit Sansthana,Varanasi,2009, p Agnivesha, Charaka, Drihabala, Charaka Samhita,Sharirasthana, Mahtigharbhavkrantiadhyaya, 4/15, Chaukhambha Surbharti Prakashana, Varanasi, 2012, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Sharirasthana, Mahtigharbhavkrantiadhyaya, 4/18, Chaukhambha Surbharti Prakashana, Varanasi, 2012, p. 884.

9 Impact factor: /ICV: Agnivesha, Charaka, Drihabala, Charaka Samhita,Sharirasthana, Mahtigharbhavkrantiadhyaya, 4/27, Chaukhambha Surbharti Prakashana, Varanasi,2012, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Sharirasthana, Jatiyasutriyaadhyaya,8/31,Chaukhambha Surbharti Prakashana, Varanasi,2012, p Agnivesha, Charaka, Drihabala, Charaka Samhita,Siddhisthana, Kalpanasiddhiadhyaya, 1/40-41, Chaukhambha Surbharti Prakashana, Varanasi, 2007, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Siddhisthana, Kalpanasiddhiadhyaya, 1/47-48 Chaukhambha Surbharti Prakashana, Varanasi, 2005, p Kashyapa, ViridhaJivaka,Vatsya, Kashyap Samhita, Khilsthana, Lehadhayya, edited by Satyapala Bhisagacharya, Chaukhambha Sanskrit Sansthana,Varanasi, 2010; p Devodas Dhanvantari,Sushruta, Susruta Samhita,Chikitsasthana, Netrabastipramanavibhagachikitsa adhyaya,35/29-30,edited by Ambika Dutta Shastri, Chaukhambha Sanskrit Sansthana,Varanasi,2009, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Siddhisthana, Kalpanasiddhiadhyaya, 1/40-41, Chaukhambha Surbharti Prakashana, Varanasi,2005, p Kashyapa,ViridhaJivaka,Vatsya,KashyapSamhita,SutraSthana,Lehadhayya,edited by Satyapala Bhisagacharya, Chaukhambha Sanskrit Sansthana,Varanasi, 2010; p Yogaratnakara,with vaidyaprabha hindi commentary, BalarodhikaraAdhyaya 6/39-42edited by Dr. Indradev Tripathi, Chaukhambha Krishnadas Academy,Varanasi, 2011,p Agnivesha, Charaka, Drihabala, Charaka Samhita, Sharirasthana, Khuddikagharbhavkrantiadhyaya, 3/31-32, Chaukhambha Surbharti Prakashana,Varanasi,2005, p Kashyapa, ViridhaJivaka,Vatsya, Kashyap Samhita, Sutrasthana Lehadhayya, edited by Satyapala Bhisagacharya, Chaukhambha Sanskrit Sansthana,Varanasi, 2010; p Acharya Priyavrata Sharma, Dravya Guna Vigyaniyam, Varanasi, Chaukhambha Bharati Academy, Varanasi,2005, p. 159,605,676,734,736, Agnivesha, Charaka, Drihabala, Charaka Samhita, Sutrasthana, Annapanavidhiadhyaya, 27/202, Chaukhambha Surbharti Prakashana, Varanasi, 2012, p Devodas Dhanvantari,Sushruta, Susruta Samhita, chikitsasthana, Netrabastipramanavibhagachikitsa adhyaya,45/26,edited by Ambika Dutta Shastri, Chaukhambha Sanskrit Sansthana,Varanasi,2009, p.220.

10 Impact factor: /ICV: Agnivesha, Charaka, Dridhabala, Chakrapani, Charaka Samhita, Sutra Sthana, 3/18, Yadavjitrikamji, Ayurveda Dipika, Chaukhamba Prakashana, Varanasi 2009,p Vagbhat, Asthanga Hridya, Sutrasthana, Dincharyaadhyaya,2/8,edited by Dr.Brahmanand Tripathi, Chaukhambha Sanskrit Pratishthana, Delhi,2011,p Agnivesha, Charaka, Drihabala, Charaka Samhita, Sutrasthana, Langhanabrumhniyaadhyaya, 22/11, Chaukhambha Surbharti Prakashana,Varanasi,2012, p Agnivesha, Charaka, Drihabala, Charaka Samhita, Siddhisthana,Kalpanasiddhiadhyaya, 1/29, Chaukhambha Surbharti Prakashana,Varanasi, 2005, p Devodas Dhanvantari,Sushruta, Susruta Samhita,chikitsasthana, Netrabastipramanavibhagachikitsa adhyaya,35/18,edited by Ambika Dutta Shastri, Chaukhambha Sanskrit Sansthana,Varanasi,2009, p Dr.vasant c. patil, Principles and practice of Panchkarma, chapter 13 Basti Karma Chaukhambha Publications, Delhi, 2014 p.496. For Correspondence Satyawati Rathia

World Journal of Pharmaceutical and Life Sciences WJPLS

World Journal of Pharmaceutical and Life Sciences WJPLS wjpls, 2017, Vol. 3, Issue 1, 290-296 Case Study ISSN 2454-2229 Shruthi et al. WJPLS www.wjpls.org SJIF Impact Factor: 4.223 AYURVEDIC MANAGEMENT OF SHIROMARMA ABHIGHATA (TRAUMATIC BRAIN INJURY) S. Shruthi

More information

Ayurlog: National Journal of Research in Ayurved Science. Review on description of Seasons in Charakasamhita

Ayurlog: National Journal of Research in Ayurved Science. Review on description of Seasons in Charakasamhita Impact factor: 2016: 5.210; 2015: 5.223 ISSN: 2320-7329 1 Ayurlog: National Journal of Research in Ayurved Science Website: http://www.ayurlog.com Volume: 6 th Issue: 7 th Oct- Dec 2018 Review on description

More information

International Journal of Applied Ayurved Research ISSN: AN OUTLOOK OF DETERMINATION OF RASAVAHASROTAS 1 Bhadiyadra Bharat L.

International Journal of Applied Ayurved Research ISSN: AN OUTLOOK OF DETERMINATION OF RASAVAHASROTAS 1 Bhadiyadra Bharat L. International Journal of Applied Ayurved Research ISSN: 2347-6362 AN OUTLOOK OF DETERMINATION OF RASAVAHASROTAS 1 Bhadiyadra Bharat L. 2 Vyas Hitesh A. 3 Vyas M. K. 1 Ph D Scholar, Basic Principles Department,

More information

TAKRA (BUTTERMILK): AN ELIXER OF EARTH. Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Thanniruhalla, Hassan, Karnataka, India.

TAKRA (BUTTERMILK): AN ELIXER OF EARTH. Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Thanniruhalla, Hassan, Karnataka, India. REVIEW ARTICLE TAKRA (BUTTERMILK): AN ELIXER OF EARTH JYOTI BJ 1, KAVITA MB 2 1 Postgraduate Scholar, 2 Associate Professor Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Thanniruhalla,

More information

Review Article International Ayurvedic Medical Journal ISSN:

Review Article International Ayurvedic Medical Journal ISSN: Review Article International Ayurvedic Medical Journal ISSN:2320 5091 A REVIEW ON CONCEPTUAL STUDY OF ANNAVAHA SROTASA Meshram D S 1, Pawar K B 2, Nikumbh M B 3, Kodape D T 4 1 Assistant Professor, 3 Professor

More information

The Karmukata of Svedana Karma: A Critical Analysis Mishra Gaurav, 1 Kumar Ashvini, 2 BA Lohith, 3 Sharma Swati. 4

The Karmukata of Svedana Karma: A Critical Analysis Mishra Gaurav, 1 Kumar Ashvini, 2 BA Lohith, 3 Sharma Swati. 4 The Karmukata of Svedana Karma: A Critical Analysis Mishra Gaurav, 1 Kumar Ashvini, 2 BA Lohith, 3 Sharma Swati. 4 1 Post Graduate Scholar, 2 Professor, 3 Associate Professor and Head, Department of Panchakarma,

More information

Bhattacharyya Nirupam et al / Int. J. Res. Ayurveda Pharm. 4(5), Sep Oct Review Article.

Bhattacharyya Nirupam et al / Int. J. Res. Ayurveda Pharm. 4(5), Sep Oct Review Article. Review Article www.ijrap.net CLINICAL APPLICATION OF SHADVIDHOPKRAMA: A CRITICAL REVIEW Bhattacharyya Nirupam 1 *, Pujar Muralidhar P 2, M Ashvini Kumar 3, Chaturvedi Ashutosh 1 1 PG Scholar, Department

More information

Impact factor: /ICV: INTEGRATING AYURVEDIC CONCEPTS OF IMMUNITY AND ITS ENHANCEMENT- A REVIEW Mamta Tiwari* 1, Anurag Pandey 2

Impact factor: /ICV: INTEGRATING AYURVEDIC CONCEPTS OF IMMUNITY AND ITS ENHANCEMENT- A REVIEW Mamta Tiwari* 1, Anurag Pandey 2 Impact factor: 0.3397/ICV: 4.10 94 Pharma Science Monitor 6(1), Jan-Mar 2015 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com INTEGRATING

More information

International Journal of Ayurveda and Pharmaceutical Chemistry

International Journal of Ayurveda and Pharmaceutical Chemistry International Journal of Ayurveda and Pharmaceutical Chemistry Volume 7 Issue 2 2017 www.ijapc.com Managed by Green m RESEARCH ARTICLE www.ijapc.com e-issn 2350-0204 The Role of Karnadhupan in the Management

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Review Article Physiological and Clinical Significance of Srotas Vd. Khendkar Jayashree Chandrakant 1, Pawar Jatved Janardanrao

More information

Sthaulya has been learned. Symptoms of thesee two have been reviewed and compared. The difference be-

Sthaulya has been learned. Symptoms of thesee two have been reviewed and compared. The difference be- Research Article International Ayurvedic Medical Journal ISSN:2320 5091 COMPARATIVE STUDY OF MEDAVRIDDHI & STHAULYAA QUOTED IN BRIHATRAYI FROM THE DESK OF KRIYA SHARIR Ohol Saritaa Vilas 1, Waghulade Hemangini

More information

Diet in Psoriasis - An Ayurvedic Perspective

Diet in Psoriasis - An Ayurvedic Perspective Review Article Diet in Psoriasis - An Ayurvedic Perspective Journal of Indian System of Medicine 1 2 Sanjeev.S.Tonni, Shamshad Begum 1 2 Asst. Prof.,Dept. of Swasthavritta, Scholar, Dept of Panchakarma,

More information

UNDERSTANDING PRAMEHA THROUGH TRISUTRA SIDDHANTA

UNDERSTANDING PRAMEHA THROUGH TRISUTRA SIDDHANTA Impact factor: 3.958/ICV: 4.10 ISSN: 0976-7908 666 Pharma Science Monitor 8(2), Apr-Jun 2017 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com

More information

World Journal of Pharmaceutical and Life Sciences WJPLS

World Journal of Pharmaceutical and Life Sciences WJPLS wjpls, 2018, Vol. 4, Issue 10, 52-56 Review Article ISSN 2454-2229 Sanglae et al. WJPLS www.wjpls.org SJIF Impact Factor: 5.088 REVIEW OF PRAMEHA WITH SPECIAL REFERENCE TO AVYAYAM HETU Vd. Anant A. Sangale

More information

International Journal of Ayurveda and Pharma Research

International Journal of Ayurveda and Pharma Research International Journal of Ayurveda and Pharma Research ISSN: 2322-0902 (P) ISSN: 2322-0910 (O) Review Article ROLE OF NIDANA PANCHAKA IN VARIOUS AYURVEDIC ASPECTS Mona Bajpai 1 *, Meenakshi Malik 1, K.Venkat

More information

REFERENCE TO EMBRYOLOGY

REFERENCE TO EMBRYOLOGY INTERNATIONAL AYURVEDIC MEDICAL JOURNAL International Ayurvedic Medical Journal, (ISSN: 2320 5091) (August, 2017) 5(8) A REVIEW ON DEVELOPMENT OF THE MOOLASTHANA OF SROTASS WITH REFERENCE TO EMBRYOLOGY

More information

Antimicrobial study of Anandbhairav Ras (Atisar Adhikar) on stock enteropathogenic bacteria w.s.r. to bacterial food poisoning

Antimicrobial study of Anandbhairav Ras (Atisar Adhikar) on stock enteropathogenic bacteria w.s.r. to bacterial food poisoning World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

A A M J Anveshana Ayurveda Medical Journal

A A M J Anveshana Ayurveda Medical Journal A A M J Anveshana Ayurveda Medical Journal wwwaamjin ISSN: 2395-4159 Review Article Critical Review on the Concept of Harish Kumar 1 Prasad Prabhakharrao Pande 2 Pradnya Deshpande 3 Harpreet Kaur 4 A b

More information

REVIEW OF HRIDROGA WITH SPECIAL REFERENCE TO VEG-VIDHARAN HETU

REVIEW OF HRIDROGA WITH SPECIAL REFERENCE TO VEG-VIDHARAN HETU Review Article International Ayurvedic Medical Journal ISSN:2320 5091 REVIEW OF HRIDROGA WITH SPECIAL REFERENCE TO VEG-VIDHARAN HETU Marathe Amruta Dilip 1, Aher Priyanka Ashok 2, Joshi Mohon Ramachandra

More information

Anatomical considerations on sira in Ayurveda with special reference to Sushruta Samhita

Anatomical considerations on sira in Ayurveda with special reference to Sushruta Samhita International Journal of Ayurvedic Medicine, 2013, 4(4), 320-327 Anatomical considerations on sira in Ayurveda with special reference to Sushruta Samhita Review Article Kumar BMN 1 *, Awasthi HH 2 1. Asstt.Professor,

More information

CONCEPTUAL STUDY ON ROLE OF LIFESTYLE MODIFICATION IN THE MANAGEMENT OF OBESITY

CONCEPTUAL STUDY ON ROLE OF LIFESTYLE MODIFICATION IN THE MANAGEMENT OF OBESITY Review Article International Ayurvedic Medical Journal ISSN:2320 5091 CONCEPTUAL STUDY ON ROLE OF LIFESTYLE MODIFICATION IN THE MANAGEMENT OF OBESITY Kodrani Priya* 1, Patel D. V. 2 * 1 P.G.Scholar, Upgraded

More information

SPREADSHEET MODELS FOR FOCUSING RESEARCH ON HIGH YIELD PREVENTION AND CONTROL STRATEGIES

SPREADSHEET MODELS FOR FOCUSING RESEARCH ON HIGH YIELD PREVENTION AND CONTROL STRATEGIES Department of Epidemiology Course EPI 415 School of Public Health University of California, Los Angeles Session 18 SPREADSHEET MODELS FOR FOCUSING RESEARCH ON HIGH YIELD PREVENTION AND CONTROL STRATEGIES

More information

A B S T R A C T INTRODUCTION. ISSN: REVIEW ARTICLE Sep-Oct 2016

A B S T R A C T INTRODUCTION. ISSN: REVIEW ARTICLE Sep-Oct 2016 Concept of Manasa Prakruti as described in Charaka Samhita Sachin S. Bagali, Umapati C. Baragi 1 Assistant Professor, 1 Reader, Department of Basic Principles, BLDEA S, AVS Ayurveda Mahavidyalaya, Vijayapur,

More information

2. Assistant Professor, Dept. Of Kriyasharir, SGR Ayurved College, Solapur Maharashtra,

2. Assistant Professor, Dept. Of Kriyasharir, SGR Ayurved College, Solapur Maharashtra, Review Article International Ayurvedic Medical Journal ISSN:2320 5091 SUSHRUTA SAMHITA COMPLETE TREATISE OF AYURVEDA- A REVIEW ARTICLE Madgundi Anand K 1 Ade Jaykumar S 2 Bhabad Pradeep R 3 Jain Atul S

More information

Selecting Foundation and Replacement Goats

Selecting Foundation and Replacement Goats Selecting Foundation and Replacement Goats G. L. M. Chappell Terry K. Hutchens Department of Animal Sciences College of Agriculture University of Kentucky The selection of goats to begin a flock or add

More information

The concept of Antimicrobial Activity in Ayurveda and the effect of some indigenous drugs on Gram-Negative Bacteria

The concept of Antimicrobial Activity in Ayurveda and the effect of some indigenous drugs on Gram-Negative Bacteria International Journal Of Ayurvedic And Herbal Medicine 1:2 (2011)27:39 Journal Homepage http://interscience.org.uk/index.php/ijahm ISSN-2249-5746 The concept of Antimicrobial Activity in Ayurveda and the

More information

Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J

Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J Record Status This is a critical abstract of an economic evaluation

More information

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23

More information

Lyme Disease. Lyme disease is a bacterial infection spread by tick bites from infected blacklegged

Lyme Disease. Lyme disease is a bacterial infection spread by tick bites from infected blacklegged Lyme Disease Lyme disease is a bacterial infection spread by tick bites from infected blacklegged ticks. The bacteria that causes the disease is Borrelia burgdorferi, a spirochete. The earliest symptoms

More information

Don t let arthritis slow down your dog!

Don t let arthritis slow down your dog! Don t let arthritis slow down your dog! abcd DOG CAT ACUTE CHRONIC PERIOPERATIVE INJECTABLE ORAL SUSPENSION CHEWABLE Keeping your dog in the prime of life Is your dog at risk of developing arthritis? As

More information

Weekly Schedule of Neuroscience (2017/2018) Week 1

Weekly Schedule of Neuroscience (2017/2018) Week 1 Week 1 28/1/2018 29/1/2018 30/1/2018 31/1/2018 1/2/2018 8:00 9:00 Health politics & 9:00 10:00 Introductory lecture Gross morphology of the brain Gross morphology of spinal cord Health politics & Blood

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection PACKAGE LEAFLET: INFORMATION FOR THE USER Amikacin 250 mg/ml Injection Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you

More information

Ajantha et al Asian Journal of Pharmaceutical Research and Development. 2018; 6(4): 86-91

Ajantha et al Asian Journal of Pharmaceutical Research and Development. 2018; 6(4): 86-91 Asian Journal of Pharmaceutical Research and Development (An International Peer-Reviewed Journal of Pharmaceutical Research and Development) 2013-18, publisher and licensee AJPRD, This is an Open Access

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT COXEVAC suspension for injection for cattle and goats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:

More information

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION: SCHEDULING STATUS S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNA CEFPODOXIME 100 mg (film coated tablet) DYNA CEFPODOXIME SUSPENSION (powder for oral suspension) Please read this leaflet carefully

More information

Delayed Prescribing for Minor Infections Resource Pack for Prescribers

Delayed Prescribing for Minor Infections Resource Pack for Prescribers Delayed Prescribing for Minor Infections Resource Pack for Prescribers Background: Antibiotic resistance is an alarming threat to modern healthcare, and infectious illness remains a major global threat

More information

Questions and answers on serious non-fatal adverse events and reporting rules

Questions and answers on serious non-fatal adverse events and reporting rules 12 April 2017 EMA/CVMP/PhVWP/303762/2012-Rev.1 Committee for Medicinal Products for Veterinary Use Questions and answers on serious non-fatal adverse events and reporting rules This questions and answers

More information

Understanding your pet s LIVER CONDITION

Understanding your pet s LIVER CONDITION Understanding your pet s LIVER CONDITION Why is the liver so important? What causes liver disease in dogs and cats? The liver is one of the largest organs in your pet s body, and it s vital for their good

More information

Author - Dr. Josie Traub-Dargatz

Author - Dr. Josie Traub-Dargatz Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary

More information

New Zealand Consumer Medicine Information

New Zealand Consumer Medicine Information New Zealand Consumer Medicine Information FLUCLOXACILLIN Flucloxacillin (as the sodium salt) 250 mg and 500 mg capsules Flucloxacillin (as the sodium salt) 125 mg/5 ml and 250 mg/5 ml powder for oral solution

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur... SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT WONDERCEF powder and solvent for solution for injection for horses not intended for the production of foods for human consumption.

More information

Full Name: Spouse/Partners Name: Home Address: Address:

Full Name: Spouse/Partners Name: Home Address:  Address: CLIENT INFORMATION Full Name: Spouse/Partners Name: Home Address: Telephone Numbers (checkmark your primary contact number): Home: Cell: Work: Email Address: Please note that we send monthly e-newsletters

More information

Feline Wellness Report

Feline Wellness Report Demo/Sample Clinic Feline Wellness Report 59 YOUR CAT'S AGE, IN HUMAN YEARS: Environment, genetics, nutrition and size are factors in determining a cat's age. Although this calculation is not exact, it

More information

Int J Ayu Pharm Chem. Preventive Health Measures in Ayurveda. Guru Sharan Pal REVIEW ARTICLE. Abstract

Int J Ayu Pharm Chem. Preventive Health Measures in Ayurveda. Guru Sharan Pal REVIEW ARTICLE. Abstract Int J Ayu Pharm Chem REVIEW ARTICLE www.ijapc.com e-issn 2350-0204 Preventive Health Measures in Ayurveda * Nitishwar Ayurveda College Muzaffarpur, Bihar, India Abstract Ayurveda emphasizes on preventive

More information

The College of Veterinarians of Ontario. Guidelines. for the Compounding of Veterinary Drugs

The College of Veterinarians of Ontario. Guidelines. for the Compounding of Veterinary Drugs The College of Veterinarians of Ontario Guidelines for the Compounding of Veterinary Drugs GUIDELINES Compounding of Veterinary Drugs Approved by Council: September 26, 2007 Publication Date: Website September

More information

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met: CLINICAL PROTOCOL F COMMUNITY ACQUIRED PNEUMONIA SCOPE: Western Australia All criteria must be met: Inclusion Criteria Exclusion Criteria CB score equal or above 1. Mild/moderate pneumonia confirmed by

More information

Early Onset Neonatal Sepsis (EONS) A Gregory ST6 registrar at RHH

Early Onset Neonatal Sepsis (EONS) A Gregory ST6 registrar at RHH Early Onset Neonatal Sepsis (EONS) A Gregory ST6 registrar at RHH Background Early onset neonatal sepsis (EONS) is a significant cause of mortality and morbidity in newborn babies. Prompt antibiotic treatment

More information

Critical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary

Critical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary Running head: ANTIBIOTIC DURATION IN AOM 1 Critical Appraisal Topic Antibiotic Duration in Acute Otitis Media in Children Carissa Schatz, BSN, RN, FNP-s University of Mary 2 Evidence-Based Practice: Critical

More information

Suitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP)

Suitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP) STUDY PROTOCOL Suitability of Antibiotic Treatment for CAP (CAPTIME) Purpose The duration of antibiotic treatment in community acquired pneumonia (CAP) lasts about 9 10 days, and is determined empirically.

More information

Dr. P. P. Doke. M.D., D.N.B., Ph.D., FIPHA. Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune

Dr. P. P. Doke. M.D., D.N.B., Ph.D., FIPHA. Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune Dr. P. P. Doke M.D., D.N.B., Ph.D., FIPHA Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune 1 Anti microbial resistance is now a global geometrically increasing threat

More information

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection. 1. NAME OF THE MEDICINAL PRODUCT Nystatin Orifarm, 100 000 IU/ml oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 100 000 IU nystatin. Excipients with known effect: - Methyl parahydroxybenzoate

More information

MINISTRY OF HEALTH, MALAYSIA

MINISTRY OF HEALTH, MALAYSIA LAMPIRAN C Ref. No : Photo 4 x 6 ( Part I : Personal information ) 1. FULL NAME ( FIRST NAME) : ( FATHER'S NAME) : 2. MALE/FEMALE : 3. AGE : 7. NAME OF EMPLOYER / RECRUITING AGENCY : 8. ADDRESS OF EMPLOYER

More information

Synopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets

Synopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets Synopsis Name of the sponsor Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets Name of active ingredient Title of the study Study

More information

Ayurvedic Aspect of Alark (Rabies) A Peer Review

Ayurvedic Aspect of Alark (Rabies) A Peer Review International Research Journal of Interdisciplinary & Multidisciplinary Studies (IRJIMS) A Peer-Reviewed Monthly Research Journal ISSN: 2394-7969 (Online), ISSN: 2394-7950 (Print) Volume-I, Issue-VIII,

More information

The rights of patients as consumers: An ancient view

The rights of patients as consumers: An ancient view Review Article The rights of patients as consumers: An ancient view Nishant Bhimraj Barapatre, Vishnu Prabhakar Joglekar 1 Department of Agadtantra, Mahila Utkarsh Pratishthan s Ayurved College, Washim,

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND

More information

Weekly Schedule of Neuroscience (2018/2019) Week 1

Weekly Schedule of Neuroscience (2018/2019) Week 1 Week 1 27/1/2019 28/1/2019 29/1/2019 30/1/2019 31/1/2019 9:00 10:00 Introductory lecture Gross morphology of the brain Gross morphology of spinal cord Health politics & Blood supply of the CNS Language

More information

IACUC Policy on Humane Endpoints in Animal Use Proposals

IACUC Policy on Humane Endpoints in Animal Use Proposals IACUC Policy on Humane Endpoints in Animal Use Proposals Definitions: moribund \MOR-uh-bund\, adjective: In a dying state; dying; at the point of death. morbid\ MOR-bid\, adjective: pertaining to, affected

More information

PROFESSIONAL PRACTICE STANDARD

PROFESSIONAL PRACTICE STANDARD PROFESSIONAL PRACTICE STANDARD Dispensing Drugs TBD Introduction Under the Veterinarians Act and Regulations, veterinarians licensed by the College of Veterinarians of Ontario are authorized to engage

More information

VETERINARY SCIENCE CURRICULUM. Unit 1: Safety and Sanitation

VETERINARY SCIENCE CURRICULUM. Unit 1: Safety and Sanitation Chariho Regional School District - Science Curriculum September, 2016 VETERINARY SCIENCE CURRICULUM Unit 1: Safety and Sanitation Students will gain an understanding of the types of hazards common in veterinary

More information

Preeja Preman et al / Int. J. Res. Ayurveda Pharm. 7(Suppl 3), Jul - Aug Review Article.

Preeja Preman et al / Int. J. Res. Ayurveda Pharm. 7(Suppl 3), Jul - Aug Review Article. Review Article www.ijrap.net COSMETIC SENSE OF AYURVEDA: A REVIEW Preeja Preman 1, Prathibha C. K 2, K. Parameswaran Namboothiri 2, Ananth Ram Sharma 2 * 1 PG Scholar, Amrita School of Ayurveda, Kollam,

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Genta 50 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active Substances Gentamicin sulphate equivalent to Gentamicin

More information

Acute Pyelonephritis POAC Guideline

Acute Pyelonephritis POAC Guideline Acute Pyelonephritis POAC Guideline Refer full regional pathway http://aucklandregion.healthpathways.org.nz/33444 EXCLUSION CRITERIA: COMPLICATED PYELONEPHRITIS Discuss with relevant specialist for advice

More information

NEONATAL Point Prevalence Survey. Ward Form

NEONATAL Point Prevalence Survey. Ward Form Appendix 2 NEONATAL Point Prevalence Survey Ward Form Please fill in one form for each ward included in PPS Date of survey Person completing form (Auditor code) Hospital Name Department/Ward Neonatal departments

More information

Unshakeable confidence

Unshakeable confidence NEW PRODUCT OF THE YEAR as voted by vets for the 2nd year running** Unshakeable confidence Osurnia is the only otitis externa* treatment that applies like a liquid and stays like a gel. Right where you

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Oncept IL-2 lyophilisate and solvent for suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

Effectiveness of Information Booklet on Knowledge Regarding Dengue Fever And Its Prevention Among Senior Secondary School Students.

Effectiveness of Information Booklet on Knowledge Regarding Dengue Fever And Its Prevention Among Senior Secondary School Students. IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 7, Issue 1 Ver. X. (Jan.- Feb.2018), PP 01-05 www.iosrjournals.org Effectiveness of Information Booklet

More information

EPAR type II variation for Metacam

EPAR type II variation for Metacam 23 June 2011 EMA/674662/2011 International Non-proprietary Name: Meloxicam Procedure No. EMEA/V/C/033/II/084 EU/2/97/004/026, 33-34 Scope: Type II Addition of indication for cats Page 1/6 Table of contents

More information

ANNEX III LABELLING AND PACKAGE LEAFLET

ANNEX III LABELLING AND PACKAGE LEAFLET ANNEX III LABELLING AND PACKAGE LEAFLET 1 A. LABELLING 2 PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE PACKAGE Card box and package leaflet for brown glass bottle (Type 1) 1. NAME OF THE

More information

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT OTOMAX EAR DROPS SUSPENSION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of the veterinary medicinal product contains:

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS Revised: January 2012 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Blackleg Vaccine 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance(s): per ml Five strains

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Fluclon 250 mg Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 250mg of flucloxacillin as flucloxacillin sodium.

More information

The Scientific review on clinical and therapeutic aspects of Jalaukavacharan (leech therapy)

The Scientific review on clinical and therapeutic aspects of Jalaukavacharan (leech therapy) World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Available online at: http://www.wjpsonline.org/ Review Article The Scientific review on clinical and therapeutic

More information

Sites of IM injections : 1. Ventrogluteal site: site is in the gluteus medius muscle, which lies over the gluteus minimus. 2. Vastus lateralis site:

Sites of IM injections : 1. Ventrogluteal site: site is in the gluteus medius muscle, which lies over the gluteus minimus. 2. Vastus lateralis site: Sites of IM injections : 1. Ventrogluteal site: site is in the gluteus medius muscle, which lies over the gluteus minimus. 2. Vastus lateralis site: is the thick and well developed in both adults and children.

More information

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long): Prescription Label Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long): Prescribing Veterinarian's Name & Contact Information: Refills: [Content to be provided

More information

ECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018

ECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018 ECHO: Management of URIs Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018 Infectious causes of URIs change over time Most ARIs are viral

More information

Scientific Discussion post-authorisation update for Rheumocam extension X/007

Scientific Discussion post-authorisation update for Rheumocam extension X/007 5 May 2011 EMA/170257/2011 Veterinary Medicines and Product Data Management Scientific Discussion post-authorisation update for Rheumocam extension X/007 Scope of extension: addition of 20 mg/ml solution

More information

Course Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine

Course Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine Course Curriculum for Master Degree in Internal Medicine/ Faculty of Veterinary Medicine The Master Degree in Internal Medicine/Faculty of Veterinary Medicine is awarded by the Faculty of Graduate Studies

More information

Prevention & Management of Infection post Trans Rectal Ultrasound (TRUS) biopsy

Prevention & Management of Infection post Trans Rectal Ultrasound (TRUS) biopsy Prevention & Management of Infection post Trans Rectal Ultrasound (TRUS) biopsy Dr. Fidelma Fitzpatrick Consultant Microbiologist, Co-chair, NCCP Prostate Bx Infection Project Board Fidelma.fitzpatrick@hse.ie

More information

Some important information about the fetus and the newborn puppy

Some important information about the fetus and the newborn puppy Some important information about the fetus and the newborn puppy Dr. Harmon Rogers Veterinary Teaching Hospital Washington State University Here are a few interesting medical details about fetuses and

More information

VETERINARY MEDICINE-VM (VM)

VETERINARY MEDICINE-VM (VM) Veterinary Medicine-VM (VM) 1 VETERINARY MEDICINE-VM (VM) Courses VM 603 Veterinary Science: Research and Methods Credit: 1 (1-0-0) Course Description: Conduct of responsible research, contributions of

More information

My cat has kidney problems and food hypersensitivity what do I do now?

My cat has kidney problems and food hypersensitivity what do I do now? TROVET Renal (Venison), complete, easily digestible, hypoallergenic dietary food for adult cats with an impaired kidney function My cat has kidney problems and food hypersensitivity what do I do now? reliable

More information

Medical Conditions Questionnaire

Medical Conditions Questionnaire Medical Conditions Questionnaire (to be completed by the member) Member Full Name.Date of birth. Policy number or scheme name. Please complete the appropriate section(s) only after completing the Member

More information

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin Package leaflet: Information for the patient FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

CAUSES OF DISPOSAL OF MURRAH BUFFALO FROM AN ORGANISED HERD

CAUSES OF DISPOSAL OF MURRAH BUFFALO FROM AN ORGANISED HERD EAMR, Vol. 1, Issue 1 - July, 2011 CAUSES OF DISPOSAL OF MURRAH BUFFALO FROM AN ORGANISED HERD S. Taraphder 1, S. S. Tomar 2, A. K. Gupta 2, P. K. Panja 3 & P. K. Biswas 4 ABSTRACT : The present study

More information

Antimicrobial Stewardship in Continuing Care. Urinary Tract Infections Clinical Checklist

Antimicrobial Stewardship in Continuing Care. Urinary Tract Infections Clinical Checklist Antimicrobial Stewardship in Continuing Care Urinary Tract Infections Clinical Checklist December 2014 What is Antimicrobial Stewardship? Using the: right antimicrobial agent for a given diagnosis at the

More information

Name Class Date. After you read this section, you should be able to answer these questions:

Name Class Date. After you read this section, you should be able to answer these questions: CHAPTER 14 4 Vertebrates SECTION Introduction to Animals BEFORE YOU READ After you read this section, you should be able to answer these questions: How are vertebrates different from invertebrates? How

More information

Drug Utilization Evalauation of Antibiotics in Dh Uttarakashi

Drug Utilization Evalauation of Antibiotics in Dh Uttarakashi IOSR Journal Of Pharmacywww.iosrphr.org (e)-issn: 2250-3013, (p)-issn: 2319-4219 Volume 7, Issue 9 Version. II (September 2017), PP. 01-05 Drug Utilization Evalauation of Antibiotics in Dh Uttarakashi

More information

The world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF

The world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF The world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF NOTHING IS SIMPLER THAN POUR-ON RELIEF FOR PAIN, FEVER AND ACUTE INFLAMMATION easy to dose easy to apply easy on animals

More information

ANNUAL STATISTICAL REPORT FOR ANIMALS USED IN IRELAND UNDER SCIENTIFIC ANIMAL PROTECTION LEGISLATION

ANNUAL STATISTICAL REPORT FOR ANIMALS USED IN IRELAND UNDER SCIENTIFIC ANIMAL PROTECTION LEGISLATION ANNUAL STATISTICAL REPORT FOR ANIMALS USED IN IRELAND UNDER SCIENTIFIC ANIMAL PROTECTION LEGISLATION 2013 CONTENTS 1. Introduction 2. Summary 3. Results 3.1 Species and numbers of naive animals used in

More information

A review of Filariasis

A review of Filariasis International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Review Article Volume 5, Issue 2-2019 DOI: http://dx.doi.org/10.22192/ijcrms.2019.05.02.005

More information

Office of Residence Life Service Animal Procedure

Office of Residence Life Service Animal Procedure Office of Residence Life Service Animal Procedure Content: I. Procedure Statement 1 II. Definitions 1 III. Requesting a Service Animal 2 IV. Animal Health & Well-being 3 V. Conflicting Health Conditions

More information

HOUSE OF REPRESENTATIVES COMMITTEE ON CRIME PREVENTION, CORRECTIONS & SAFETY FINAL ANALYSIS

HOUSE OF REPRESENTATIVES COMMITTEE ON CRIME PREVENTION, CORRECTIONS & SAFETY FINAL ANALYSIS BILL #: CS/HB 1819 HOUSE OF REPRESENTATIVES COMMITTEE ON CRIME PREVENTION, CORRECTIONS & SAFETY FINAL ANALYSIS **AS PASSED BY THE LEGISLATURE** CHAPTER #: 2002-176, Laws of Florida RELATING TO: SPONSOR(S):

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Excipients: Contains 4% w/w cetyl alcohol and 7% w/w propylene glycol.

SUMMARY OF PRODUCT CHARACTERISTICS. Excipients: Contains 4% w/w cetyl alcohol and 7% w/w propylene glycol. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT FLAMAZINE Cream 1 % w/w 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Contains Silver sulfadiazine 1 % w/w Excipients: Contains 4% w/w

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Covexin 10 Suspension for injection for sheep and cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Potency

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS page 1 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Panacur PetPaste 187.5 mg/g oral paste for dogs and cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 g oral

More information

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection

More information

B. PACKAGE LEAFLET 1

B. PACKAGE LEAFLET 1 B. PACKAGE LEAFLET 1 PACKAGE LEAFLET FOR: Cadorex 300 mg/ml solution for injection for cattle, sheep and pigs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION

More information

Antibiotic stewardship in long term care

Antibiotic stewardship in long term care Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts

More information

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.

More information